Frontiers in Cardiovascular Medicine

MARCH 3, 2024

Background Objective tools to define the optimal time for referral for advanced therapies and to help guide escalation and de-escalation of support can improve management decisions and outcomes for patients with advanced heart failure. Results Approximately 1010 discrete heart failure scenarios were modeled.

Heart Failure 85

Heart Failure Cardiogenic Shock Physiology Transplant 85

DAIC

FEBRUARY 21, 2024

As the only pediatric heart transplant program in Louisiana and the only program in the state to offer advanced mechanical support options for pediatric cardiology patients, Ochsner Children’s Hospital is committed to advocating for additional medical devices to enhance its high-quality care to pediatric patients awaiting transplant.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

Medical Xpress - Cardiology

FEBRUARY 12, 2024

Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. While the procedure offers hope, the long-term outcomes for these young patients remain suboptimal due to allograft rejection and graft failure.

Transplant 62

Transplant Pediatrics Heart Transplant Heart Failure 62

DAIC

JUNE 24, 2024

Kittleson, director of Heart Failure Research and director of Post Graduate Medical Education in Heart Failure and Transplantation, is an associate editor specializing in heart failure. Levine Early Career Clinical Investigator Award from the American Heart Association.

Heart Failure 100

Heart Failure Transplant Research Interventional Cardiology 100

Frontiers in Cardiovascular Medicine

JANUARY 25, 2024

The implantation of left ventricular assist devices (LVADs) has been increasing, with good long-term results, in parallel with a growing population with advanced heart failure (HF). However, in some European countries, LVADs are still underused, with one of the main issues being the patient's late referral.

Bicuspid/Mitral 69

Bicuspid/Mitral Heart Failure Heart Transplant Transplant 69

HCPLive

MAY 21, 2024

Ashley Malliett, DMSc, MPAS, PA-C, discusses the importance of timely diagnosis and initiated care, as well as contraindications for transplants and LVAD.

Heart Failure 52

Heart Failure Transplant Outcomes 52

DAIC

DECEMBER 8, 2023

The DRAIN-HF study will evaluate the Aortix percutaneous mechanical circulatory support (pMCS) technology in patients with acute decompensated heart failure (ADHF) who are unresponsive to standard medical therapy. I am excited to be able to include the advanced heart failure patients in the trial," commented Dr. Grafton.

Technology 113

Technology Heart Failure Heart Transplant Transplant 113

Open Heart

NOVEMBER 25, 2022

Objective The role of hyperuricaemia as a prognostic maker has been established in chronic heart failure (HF) but limited information on the association between plasma uric acid (UA) levels and central haemodynamic measurements is available. UA) was used to estimate the effect on outcome associated with a 10% increase in UA levels.

Heart Failure 52

Heart Failure Outcomes Heart Transplant Artificial Heart 52

HeartRhythm

OCTOBER 7, 2024

Arrhythmias can lead to cardiac arrest (CA) and heart failure. When intractable, heart transplant (HTX) can become the only viable treatment. This rare, high-risk cohort has not been reported as a distinct group.

Heart Transplant 40

Heart Transplant Transplant Arrhythmia Cardiac Arrest 40

Circulation: Heart Failure

FEBRUARY 1, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups.

Heart Failure 40

Heart Failure Congenital Heart Disease Congenital Outcomes 40

Circulation

NOVEMBER 11, 2024

Heart transplant rates were low but increased slightly in 2020 for patients without CHD, with DV and SV CHD patients showing fluctuating rates peaking in 2018 and 2019, then declining in 2020. Patients without CHD were older (mean age 71.5 years) than those with DV-CHD (mean age 59.8 years) and SV-CHD (mean age 17.9

Cardiogenic Shock 40

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital 40

Circulation: Heart Failure

MARCH 8, 2024

Circulation: Heart Failure, Ahead of Print. Centers performing at least 1 heart transplant or left ventricular assist device were classified as ATCs. Patient characteristics, outcomes, and procedural volume were compared among 3 cohorts: admissions to non-ATCs, admissions to ATCs, and transfers to ATCs.

Heart Failure 40

Heart Failure Cardiogenic Shock Outcomes Cardiac Arrest 40

Circulation: Cardiovascular Imaging

APRIL 2, 2024

BACKGROUND:In heart transplant recipients, right ventricular (RV) dysfunction may occur for a variety of reasons. Whether RV dysfunction in the stable phase after heart transplantation is associated with long-term adverse outcomes is unknown. years after heart transplantation were included.

Heart Transplant 40

Heart Transplant Transplant Outcomes Myocardial Infarction 40

Circulation

MARCH 11, 2024

Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Acute heart failure has an incidence ranging from 0.4% Cardiovascular evaluations are crucial in pretransplantation assessments, but guidelines are lacking.

Transplant 45

Transplant Cardiovascular Disease Atrial Fibrillation Pediatrics 45

European Journal of Heart Failure

DECEMBER 13, 2023

Venn diagram of iron deficiency (ID) according to various definitions and associated outcomes. Abstract Aims There is uncertainty about the definition of iron deficiency (ID) and the association between ID and prognosis in patients with advanced heart failure. Non-scaled VENN diagram.

Heart Failure 40

Heart Failure Heart Transplant Transplant Pulmonary 40

DAIC

APRIL 30, 2024

Study shows that cardiac spheroids, derived from human induced pluripotent stem cells, can be easily transported and injected into damaged areas of the heart to promote its regeneration and recovery of function. The highly positive outcomes observed in primate models highlight the potential of this strategy.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart attacks 105

Circulation

NOVEMBER 11, 2024

Heart transplantation remains a vital treatment for end-stage heart failure, yet the scarcity of suitable donor hearts makes the treatment unavailable to many patients in critical need. Addressing this critical barrier could potentially improve post-transplant outcomes and make older donor hearts a viable option.

Transplant 40

Transplant Heart Transplant Heart Dysfunction Heart Failure 40

European Journal of Heart Failure

OCTOBER 3, 2023

Characteristics of heart failure with improved ejection fraction (HFimpEF) patients and outcome comparison with heart failure with persistently reduced ejection fraction (pHFrEF). CV mortality is the composite endpoint for CV mortality + urgent transplant + left ventricular assist device implantation.

Heart Failure 40

Heart Failure Exercise Laboratory Transplant 40

European Journal of Heart Failure

DECEMBER 1, 2024

Summary of key study outcomes. 5+) support is effective in facilitating heart recovery, overall survival, and quality of life. Methods and results This single-centre retrospective study examined midterm (180 days) outcomes of patients with CS supported by Impella 5+ who achieved heart recovery.

Cardiogenic Shock 40

Cardiogenic Shock Heart Transplant Outcomes Transplant 40

Circulation: Heart Failure

NOVEMBER 6, 2023

Circulation: Heart Failure, Ahead of Print.

Heart Transplant 40

Heart Transplant Transplant Heart Failure Circulation 40

European Journal of Heart Failure

NOVEMBER 9, 2023

Abstract Aim Cardiac resynchronization therapy (CRT) is a cornerstone in the management of chronic heart failure in patients with a broad or paced QRS. However, data on long-term outcome after upgrade to CRT are scarce. The secondary endpoint was first heart failure admission. ml/min/1.73 m ml/min/1.73 m

Outcomes 40

Outcomes Heart Failure Heart Transplant Transplant 40

Heart BMJ

DECEMBER 15, 2023

The associations between PPM implantation and mortality, heart failure (HF) or a composite endpoint of mortality, cardiac transplantation and HF were analysed. Clinical, laboratory and instrumental data were analysed. Results 81 (10.3%) patients had a PPM before initial evaluation. Over a median follow-up time of 21.7

Pacemaker 52

Pacemaker Outcomes Laboratory Transplant 52

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 12, 2024

BACKGROUND:A growing number of patients with tetralogy of Fallot develop left ventricular systolic dysfunction and heart failure, in addition to right ventricular dysfunction. Outcomes were analyzed at early (3 months), intermediate (1 year), and late follow-up (≥2 years) after CRT implantation.RESULTS:A total of 44 patients (40.3±19.2

Congenital Heart Disease 40

Congenital Heart Disease Outcomes Electrophysiology Congenital 40

Circulation

NOVEMBER 11, 2024

We collected demographic, pre-procedural, procedural, and outcome-related variables. The association between a lower rate of MAE and EMB persisted in the multivariate model when those with heart transplant who had EMB were compared to those without heart transplant who did not have EMB p=0.001. were females.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

Circulation

NOVEMBER 11, 2024

Background:Cardiac transplantation remains the single most effective treatment for end-stage heart failure. Despite the routine use of anti-rejection drugs in clinical practice, approximately 40% of cardiac transplant patients still experience unavoidable rejection. at POD 7 days; P<0.001).

Transplant 40

Transplant Heart Failure Circulation Outcomes 40

All About Cardiovascular System and Disorders

FEBRUARY 24, 2024

A study published in JACC has compared the phenotypic expression and clinical outcomes in patients with arrhythmogenic cardiomyopathy [2]. Heart failure, heart transplantation and death by cardiac causes were more often seen in individuals with biventricular phenotype compared to isolated left or right ventricular phenotype.

Cardiomyopathy 52

Cardiomyopathy Chest Pain Heart Transplant Myocardial Infarction 52

Circulation

JANUARY 18, 2024

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) use to provide hemodynamic support for acute myocardial infarction has grown exponentially, is associated with poor outcomes, and is under active clinical investigation, yet the mechanistic effect of VA-ECMO on myocardial damage in acute myocardial infarction remains poorly understood.

Myocardial Infarction 45

Myocardial Infarction Heart Transplant Ischemia Transplant 45

Cardiometabolic Health Congress

NOVEMBER 16, 2023

Key findings presented at the conference included disparities in access to kidney transplantation and waitlisting based on race and neighborhood characteristics, racial and ethnic differences in incident chronic kidney disease (CKD), and the use of motivational strategies to improve dialysis nonadherence among African American patients.

Kidney Disease 52

Kidney Disease Blood Pressure Diabetes Hospital 52

Cardiology Update

APRIL 9, 2024

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). The percent change from baseline in fasting triglycerides (TG) at six months served as the primary outcome measure.

Myocardial Infarction 52

Myocardial Infarction Angina Aortic valve Coronary Artery Disease 52

Cardiometabolic Health Congress

AUGUST 8, 2024

This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. 4 Keys To Partnering With Patients: The Cornerstone of Effective Cardiorenal Metabolic Management At the heart of any successful healthcare intervention lies the patient.

Education 59

Education Kidney Disease Cardiovascular Disease Diabetes 59

Dr. Sanjay Gupta

MARCH 6, 2022

So she went back in 4 weeks and this time saw another doctor who asked her to stop the inhalers and suggested that it could be her heart and organised a chest X-ray and blood tests. Medications that improve quality of life in heart failure for example include diuretics.

Chronic Disease 40

Chronic Disease Quality of Life Heart Failure Nursing 40

Dr. Smith's ECG Blog

JANUARY 9, 2023

He was transitioned to oral heart failure medications and discharged home slightly over one week after presentation. He was readmitted a few weeks later for a heart failure exacerbation, diuresed, and discharged again. The last information available is that the patient was undergoing heart transplant evaluation.

Chest Pain 52

Chest Pain Aneurysm STEMI Thrombosis 52

DAIC

JUNE 24, 2024

a privately held company dedicated to advancing the treatment of heart failure ( HF ) at the intersection of digital health and medtech, today announced Premarket Approval (PMA) from the U.S milla1cf Mon, 06/24/2024 - 20:21 June 24, 2024 — Endotronix, Inc. ,

Heart Failure 109

Heart Failure Reimbursement Heart Transplant Pulmonary 109

Circulation: Heart Failure

FEBRUARY 20, 2024

Circulation: Heart Failure, Ahead of Print. Background:Black heart transplant patients are at higher risk of acute rejection (AR) and death than White patients. The primary composite outcome occurred in 43% and 55% of Black patients at 1 and 2 years, compared with 23% and 27% in White patients,P<0.001.

Heart Transplant 40

Heart Transplant Transplant Heart Failure Outcomes 40

Journal of the American Heart Association

JANUARY 3, 2024

BackgroundThe extent to which sex, racial, and ethnic groups receive advanced heart therapies equitably is unclear. Our primary outcome measures were the number of LVAD and HT procedures per 1000 adults with HFrEF. The main exposures were sex, race, ethnicity, and age.

Heart Transplant 45

Heart Transplant Transplant Heart Failure Inpatient 45

European Journal of Heart Failure

NOVEMBER 7, 2023

BNP, CMR-LVEF and SUVmax in FDG-PET: independent predictors of outcome in a contemporary cardiac sarcoidosis population remaining robust in subgroup subanalysis. Here, we describe baseline characteristics at presentation along with prognosis and predictors of outcome in a sizable and deeply phenotyped contemporary cohort of CS patients.

Sudden Cardiac Death 40

Sudden Cardiac Death Outcomes Heart Transplant Heart Failure 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52